If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUil Fin 24 Regulatory News (UTLG)

  • There is currently no data for UTLG

Publication of Monthly Factsheet

13 Mar 2024 10:13

RNS Number : 6958G
UIL Limited
13 March 2024
 

13 March 2024

 

UIL LIMITED

(LEI Number: 213800CTZ7TEIE7YM468)

 

Publication of monthly factsheet

 

The latest monthly factsheet for UIL Limited ("UIL" or the "Company") will shortly be available through the Company's website at:

https://www.uil.limited/investor-relations/factsheet-archive

 

Monthly commentary

 

PERFORMANCE

UIL's NAV total return was down by 6.5% in February, behind the FTSE All Share total return Index which increased marginally by 0.2% over the month.

 

Global markets were fairly strong in February despite the more hawkish message from the US Federal Reserve that interest rates are likely to remain higher for longer as economic data from the US continued to be resilient. The US composite Purchasing Managers' Index (PMI) remained in expansionary territory and January's US nonfarm payroll data was ahead of expectations. The US market was also supported by the positive 4Q 2023 earnings reported (five of the 'Magnificent Seven' released results broadly meeting or exceeding expectations), helping to drive the S&P Index up by 5.2% over period and reaching a new all-time high in February.

 

The Eurostoxx Index followed suit up 4.9% over the period as data for February indicated that there was a pick-up in economic activity with the flash eurozone PMI up to 48.9 from 47.9 in January. Further inflationary pressures reduced with the eurozone CPI reducing to 2.6%. Market performance in the UK was essentially flat, despite data pointing to an improving outlook, as GDP fell in the final quarter of 2023 by 0.3% dragging the UK into technical recession.

 

Sterling's performance was mixed in February - down 0.7% against the US Dollar, down 0.3% against the Euro but up 0.8% against the Australian Dollar.

 

In emerging markets, the Chinese Shanghai Composite Index ended the month where it started the year, up by 8.1% for February. The market was boosted by more positive activity data over the Lunar New Year period as well as more supportive economic and financial measures being announced by the government such as cutting the five-year loan prime rates (benchmark for mortgage rates) by 25bps and banning short selling. The Hang Seng Index was also up by 6.6%. Elsewhere in Asia the markets were also positive with the Vietnamese Ho Chi Minh Index up by 7.6%, the Philippines market up by 4.5% whilst India saw a more modest increase, with the Sensex Index up by 1.2%. 

 

In Latam, the outperformer for the month was Chile, with the IPSA Index up by 7.7% whist in Brazil the market remained subdued, with the Bovespa Index up by 1.0%, slowing down after its strong rally at the end of 2023. The Mexican market was down by 3.4% hampered partly by January's inflationary figures which were reported higher than expected resulting in Banxico (Mexico's central bank) keeping interest rates at 11.25%. Further, Mexico's President Andrés Manuel López Obrador recently proposed reforms created additional noise in the market.

 

In the commodities markets, industrial metals were mixed in February, with copper down by 1.8% but nickel seeing a rebound in pricing, up 10.3%. Precious metals were also mixed with gold up marginally by 0.2% but silver down 1.2%. Oil prices continued to creep up, increasing by 2.3% for the month.

 

PORTFOLIO

There were no changes to the top ten constituents of the UIL portfolio in February.

 

Somers' valuation decreased by 6.3%. The fall in price was mainly the result of Somers' second largest holding, Resimac, whose share price fell by 12.8% over the month as investors took some profit on the back of the recent strong rally in the sector based around rate cut expectations providing a soft landing in mid 2024. During February, one of Australia's largest mortgage lenders also warned of the increasing financial strain on consumers. UIL also holds a significant direct investment in Resimac.

 

Somers entered into an agreement which resulted in the merger of Waverton Investment Management Limited ("Waverton") with London & Capital Group. UIL owns 41.7% of Somers and Waverton is Somers' largest holding. Waverton is an independent investment management business with over £10bn in assets under management. The transaction will result in Somers receiving two thirds of its consideration in cash on completion together with a significant shareholding in the combined new business. The transaction is subject to various conditions, including regulatory approvals and is expected to complete in mid 2024.

 

Zeta's share price increased by 1.9% over the month.

 

UEM's share price declined by 2.4% in February, as it delivered a NAV total return of 0.6%, underperforming the MSCI Emerging Markets total return Index which was up by 5.6% in Sterling terms in the month. UEM's discount to NAV widened from 14.5% to 17.0%.

 

DEBT

Bank debt was reduced by £5.0m to £10.0m over the month all drawn in Sterling. Other debt increased from £7.2m to £9.9m in February.

 

ZDP SHARES

In February, the share price of the 2024 ZDP shares appreciated by 1.6% whilst the 2026 ZDP shares remained flat and the 2028 ZDP shares fell 1.0%. 

 

OTHER

UIL's ordinary share price decreased by 6.1% to 115.50p in February while the discount to NAV was broadly unchanged from 39.6% to 39.3%. The second quarterly interim dividend of 2.00p per ordinary share in respect of the year ending 30 June 2024, was declared and will be paid on 4 June 2024 to shareholders on the register on 10 May 2024.

 

 

 

Name of contact and telephone number for enquiries:

 

Charles Jillings

ICM Investment Management Limited +44(0)1372 271486

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCSFEFSDELSEFD
Date   Source Headline
1st Nov 20244:59 pmRNSTransaction in Own Shares & Total Voting Rights
1st Nov 202412:45 pmRNSNet Asset Value(s)
31st Oct 202412:04 pmRNSRedemption of 2024 ZDP Shares
31st Oct 202411:29 amRNSNet Asset Value(s)
30th Oct 202411:48 amRNSNet Asset Value(s)
29th Oct 202411:28 amRNSNet Asset Value(s)
28th Oct 202412:13 pmRNSNet Asset Value(s)
25th Oct 202412:09 pmRNSNet Asset Value(s)
24th Oct 202412:52 pmRNSNet Asset Value(s)
23rd Oct 202412:05 pmRNSNet Asset Value(s)
22nd Oct 20244:47 pmRNSPurchase of 2028 ZDP Shares
22nd Oct 202412:18 pmRNSNet Asset Value(s)
21st Oct 202412:46 pmRNSNet Asset Value(s)
18th Oct 202412:59 pmRNSNet Asset Value(s)
17th Oct 202412:38 pmRNSNet Asset Value(s)
17th Oct 202411:44 amRNSPublication of monthly factsheet
16th Oct 202412:47 pmRNSNet Asset Value(s)
15th Oct 202412:17 pmRNSNet Asset Value(s)
14th Oct 20245:05 pmRNSTotal Voting Rights
14th Oct 202411:36 amRNSNet Asset Value(s)
11th Oct 202412:47 pmRNSNet Asset Value(s)
11th Oct 20247:00 amRNSRedemption of 2024 ZDP Shares
10th Oct 20245:27 pmRNSDirector/PDMR Shareholding - Shillson
10th Oct 20245:26 pmRNSDirector/PDMR Shareholding - Hill
10th Oct 20245:26 pmRNSDirector/PDMR Shareholding - Durhager
10th Oct 20245:25 pmRNSDirector/PDMR Shareholding - Bridges
10th Oct 202411:53 amRNSNet Asset Value(s)
10th Oct 20247:00 amRNSAcquisition of shares in Zeta Resources Limited
9th Oct 202412:13 pmRNSNet Asset Value(s)
8th Oct 20244:30 pmRNSAnnual Financial Report
8th Oct 20244:30 pmRNSAnnual Financial Report
8th Oct 202412:54 pmRNSNet Asset Value(s)
8th Oct 20247:00 amRNSPortfolio update – Zeta Resources Limited
7th Oct 202412:14 pmRNSNet Asset Value(s)
4th Oct 202412:43 pmRNSNet Asset Value(s)
3rd Oct 202412:07 pmRNSNet Asset Value(s)
2nd Oct 202411:59 amRNSNet Asset Value(s)
1st Oct 20242:02 pmRNSNet Asset Value(s)
30th Sep 202412:56 pmRNSNet Asset Value(s)
27th Sep 202412:55 pmRNSNet Asset Value(s)
26th Sep 202412:26 pmRNSNet Asset Value(s)
25th Sep 202412:18 pmRNSNet Asset Value(s)
24th Sep 202412:48 pmRNSNet Asset Value(s)
23rd Sep 202412:11 pmRNSNet Asset Value(s)
23rd Sep 20247:00 amRNSPublication of monthly factsheet
20th Sep 202412:36 pmRNSNet Asset Value(s)
19th Sep 20241:12 pmRNSNet Asset Value(s)
18th Sep 202412:56 pmRNSNet Asset Value(s)
17th Sep 202412:46 pmRNSNet Asset Value(s)
16th Sep 202412:18 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.